Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00583999 · ClinicalTrials.gov registry record
The Role of Leptin Receptors in NASH
A clinical trial of Metabolic Syndrome and Nonalcoholic Steatohepatitis, sponsored by University of California, Davis.
- Completed
- Registry status
- 104
- Enrollment target
- 1
- Study location
NCT00583999 is a study of Metabolic Syndrome and Nonalcoholic Steatohepatitis that has completed, run by University of California, Davis. The registered enrollment target is 104 participants, below the 1,204-participant average among 102 other Metabolic Syndrome trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00583999, a study of Metabolic Syndrome and Nonalcoholic Steatohepatitis, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- 104 participants
- Enrollment target
- 1
- Study location
Study Summary
NAFLD is a spectrum of liver diseases associated with varying degrees of hepatic steatosis, inflammation, and in some cases, fibrosis. NAFLD is a common observation in all demographics, but the prevalence of NAFLD and nonalcoholic steatohepatitis (NASH) is especially high in the morbidly obese population. Leptin is a cytokine that is encoded by the ob gene and primarily secreted by adipose tissue. The production of serum leptin increases with progressive obesity. Because of this observation, there has been significant interest in potential role of leptin in NAFLD. Our hypothesis is that we will find increased hepatic leptin and leptin receptor expression as the degree of hepatic injury worsens in NAFLD.
Conditions Studied
Interventions
- OTHER no interventions, only regular blood-draw
Study Locations (1)
California
- UC Davis Medical Center - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2006-01 |
| Est. Completion | 2009-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00583999
The ClinicalTrials.gov registry entry for NCT00583999 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 104 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,204-participant average among 102 other Metabolic Syndrome trials with a reported enrollment target (91% lower). The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Metabolic Syndrome appearing as the primary indexed condition, and to 1 intervention - of which no interventions, only regular blood-draw is the first listed.
NCT00583999 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00583999 about?
NCT00583999 is a clinical study titled "The Role of Leptin Receptors in NASH". NAFLD is a spectrum of liver diseases associated with varying degrees of hepatic steatosis, inflammation, and in some cases, fibrosis. NAFLD is a common observation in all demographics, but the prevalence of NAFLD and nonalcoholic steatohepatitis (NASH) is especially high in the morbidly obese popul...
What is the current status of trial NCT00583999?
This trial is currently completed. The enrollment target is 104 participants. The study started on 2006-01. Estimated completion is 2009-06.
What conditions does trial NCT00583999 study?
This clinical trial studies the following conditions: Metabolic Syndrome, Nonalcoholic Steatohepatitis.
What interventions are being tested in trial NCT00583999?
The interventions under investigation include: no interventions, only regular blood-draw (OTHER).
Who is sponsoring clinical trial NCT00583999?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00583999 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metabolic Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Animal and Plant Proteins and Glucose Metabolism
RECRUITING · NA
-
Combined Oral Contraceptive Pill and Resistance Starch
RECRUITING · Phase 2
-
VR Stimulation of Exercise Response in Sedentary Humans
RECRUITING · NA
-
Impact of Supplemental Fiber on Gut and Vascular Health Related in Obesity Phenotypes
RECRUITING · NA
-
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.